SSA ‐ ZP on Scalp Seborrheic Dermatitis: Regulating Sebum Levels and Scalp Barrier
Journal of Cosmetic Dermatology · 2025-01 · 24 (1)
DOI: 10.1111/jocd.16617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 28.10.2024. Verfasst von Qi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Dermatitis, Seborrheic, Sebum, Salicylic Acid, Scalp Dermatoses. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, GuangDong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Background
The occurrence of scalp seborrheic dermatitis (SD) is closely related to the production of sebum and scalp barrier function. Supramolecular salicylic acid has the keratolytic and anti‐inflammatory properties, and zinc pyrithione is an antifungal drug delivered as a microparticle to skin epithelia.
Objective
This study aimed to assess the efficacy and safety of 2% supramolecular salicylic acid (SSA) combined with 0.8% zinc pyrithione conditioner (SSA‐ZP) in treating scalp SD focusing on key outcome measures including sebum levels and scalp barrier function.
Methods
Five patients with mild to moderate scalp SD were included in the 2‐week self‐controlled prospective study, receiving daily SSA‐ZP treatment. Evaluation on days 0, 7, and 14 included dermoscopy, the adherent scalp flaking scale (ASFS), sebum level, transepidermal water loss (TEWL), pH, and stratum corneum hydration. We also performed the fungal count across specific scalp regions, such as the left and right sides of the forehead, the top of the head, and the occiput.
Results
Five patients with mild to moderate scalp SD participated in this study. After 2 weeks of SSA‐ZP treatment, significant reductions in ASFS scores, sebum levels, and fungal count were observed, alongside improvements in TEWL and pH values across multiple scalp regions. Moreover, there was no difference in the hydration of stratum corneum.
Conclusion
SSA‐ZP demonstrated efficacy in treating scalp SD without adverse effects, suggesting its potential as a first‐line treatment option. Further research with larger sample sizes and longer follow‐up periods is warranted to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Dermatology and Venereology, Fuyang People's Hospital, Fuyang, China.
- Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Qi Wang, Xiaowen Huang, Yue Zheng
Förderung
- Natural Science Foundation of Guangdong Province
- GuangDong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wang, Q., Liu, Y., Ye, C., Shen, J., Lin, J., Du, Y., Li, L., Huang, X., & Zheng, Y. (2025). SSA ‐ ZP on Scalp Seborrheic Dermatitis: Regulating Sebum Levels and Scalp Barrier. Journal of Cosmetic Dermatology, 24(1). https://doi.org/10.1111/jocd.16617
Vancouver
Wang Q, Liu Y, Ye C, Shen J, Lin J, Du Y, et al. SSA ‐ ZP on Scalp Seborrheic Dermatitis: Regulating Sebum Levels and Scalp Barrier. Journal of Cosmetic Dermatology. 2025;24(1). doi:10.1111/jocd.16617
BibTeX
@article{Wang2025,
author = {Wang, Qi and Liu, Yufang and Ye, Congxiu and Shen, Jing and Lin, Jiahui and Du, Yunfan and Li, Lintong and Huang, Xiaowen and Zheng, Yue},
title = {SSA ‐ ZP on Scalp Seborrheic Dermatitis: Regulating Sebum Levels and Scalp Barrier},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {1},
doi = {10.1111/jocd.16617}
}
EUVIMED